Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | STRO Sutro Biopharma, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $16.13 +0.1% | $15.65 -4.0% |
| StockIQ Score | 51C- Moderate Risk: High | 41D Weak Risk: High |
| Technical | 38F | 36F |
| Fundamental | 42D | 35F |
| Growth | 71B | 50C- |
| Fair Value | 50C- | 38F |
| News | 74B | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Sutro Biopharma (STRO) outperforms Ascentage Pharma (AAPG) in growth and overall investor rating. STRO’s growth score is 71, far above AAPG’s 50, while its investor rating is "Moderate" versus AAPG’s "Weak." STRO also leads in valuation (50 vs. 38) and fundamental scoring (42 vs. 35), though AAPG has a slightly higher technical score (36 vs. 38).
